Jun 22, 2021 / 04:00PM GMT
Andrew Cooper - Raymond James Financial, Inc. - Analyst
Good morning or afternoon on the East Coast at this point, and welcome to day 2 of the Raymond James Human Health Innovation Conference. Thanks for joining us. I am Andrew Cooper. I cover diagnostics here for Raymond James.
And I'm excited to be joined by Semler Scientific for a presentation this morning. It's a company that has bring some unique capabilities and frankly a unique channel approach to testing for peripheral artery disease, which is dramatically underdiagnosed in the US. But I will leave it to the team to offer more details there.
Before I do turn it over, we will have some time at the end for Q&A, so please feel free to submit any questions. (Conference Instructions) With that, like I said, we are happy to be joined by the Semler team: CEO, Doug Murphy-Chutorian; and Chief Marketing Officer, Dennis Rosenberg. And I will hand it over to you guys to begin the presentation. Thanks.
Dennis Rosenberg - Semler Scientific, Inc. - CMO
Hello. This is Dennis Rosenberg, Chief
Semler Scientific Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot